ARROWHEAD PHARMACEUTICALS IN (ARWR) Institutional Ownership and Insiders Activity

ARROWHEAD PHARMACEUTICALS IN (ARWR) is widely held by institutional investors, with 2 tracked firms reporting positions valued at approximately $65.21M based on SEC Form 13F filings for the quarter ended March 31, 2026.

Renaissance Technologies LLC is the largest disclosed holder, reporting approximately $64.99M in ARWR holdings in its latest filing.

Institutional ownership among tracked investors remains highly concentrated, with Renaissance Technologies LLC representing the majority of disclosed value.